Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Kamonphat Wongtaweepkij, Janet Krska, Supawinee Pongpunna, Juraporn Pongwecharak & Narumol Jarernsiripornkul. (2022) Thai Patients’ Drug Safety Knowledge and Perceptions Relating to Different Forms of Written Medicine Information: A Comparative Study. Patient Preference and Adherence 16, pages 1141-1152.
Read now
Read now
Muhammad Junaid Hassan Sharif, Muhammad Junaid Farrukh, Faiz Ullah Khan, Qasim Khan, Sardar Shabbir Ahmed, Rozina Kousar, Tawseef Ahmad, Syed Mobasher Ali Abid, Muhammad Ashfaq & Shujaat Ali Khan. (2022) Exploring the factors and barriers of healthcare professionals in tertiary care hospitals toward pharmacovigilance: a multicenter study from Khyber Pakhtunkhwa, Pakistan. Current Medical Research and Opinion 38:4, pages 595-605.
Read now
Read now
Articles from other publishers (12)
Catarina Costa, Patricia Abeijon, Daniela A. Rodrigues, Adolfo Figueiras, Maria Teresa Herdeiro & Carla Torre. (2023) Factors associated with underreporting of adverse drug reactions by patients: a systematic review. International Journal of Clinical Pharmacy 45:6, pages 1349-1358.
Crossref
Crossref
Warisara Srisuriyachanchai, Anthony R. Cox, Sirinya Kampichit & Narumol Jarernsiripornkul. (2023) Severity and Management of Adverse Drug Reactions Reported by Patients and Healthcare Professionals: A Cross-Sectional Survey. International Journal of Environmental Research and Public Health 20:4, pages 3725.
Crossref
Crossref
Ningsheng Wang, Yue Chen, Biqi Ren, Yufang Xiang, Nan Zhao, Xianyan Zhan & Bianling Feng. (2022) A cross-sectional study: comparison of public perceptions of adverse drug reaction reporting and monitoring in eastern and western China. BMC Health Services Research 22:1.
Crossref
Crossref
Catherine Waldron, John Hughes, Emma Wallace, Caitriona Cahir & Kathleen Bennett. (2022) Contexts and mechanisms relevant to General Practitioner (GP) based interventions to reduce adverse drug events (ADE) in community dwelling older adults: a rapid realist review. HRB Open Research 5, pages 53.
Crossref
Crossref
Zakir Khan, Khayal Muhammad, Yusuf Karatas, Cagri Bilen, Farman Ullah Khan & Faiz Ullah Khan. (2020) Pharmacovigilance and incidence of adverse drug reactions in hospitalized pediatric patients: a mini systematic review. Egyptian Pediatric Association Gazette 68:1.
Crossref
Crossref
Chanthawat Patikorn, Wimon Suwankesawong, Noppadon Adjimatera, Thanisa Thathong, Poonyawee Luksameesate, Nattanichcha Kulthanachairojana, Kittinop Kittirotruji, Doungporn Leelavanich & Puree Anantachoti. 2020. Drug Safety in Developing Countries. Drug Safety in Developing Countries
255
278
.
Phantipa Sakthong. (2019) Pharmacotherapy related quality of life in Thai patients with chronic diseases. International Journal of Clinical Pharmacy 41:4, pages 1004-1011.
Crossref
Crossref
Doaa Alkhalidi, Shazia Qasim Jamshed, Ramadan Mohamed Elkalmi, Mirza Rafi Baig, Adeel Aslam & Mohamed Azmi Hassali. (2019) General Public Views, Attitudes, and Experiences toward Drug Safety in Dubai, United Arab Emirates: A Qualitative Approach. Pharmacy 7:1, pages 19.
Crossref
Crossref
Narumol Jarernsiripornkul, Pacharaporn Phueanpinit, Juraporn Pongwecharak & Janet Krska. (2019) Development and evaluation of user-tested Thai patient information leaflets for non-steroidal anti-inflammatory drugs: Effect on patients’ knowledge. PLOS ONE 14:1, pages e0210395.
Crossref
Crossref
Arief Mohammad, Harika Bheemavarapu, Muhammad Umair Khan, Anam Khan, Akram Ahmad, Mohamed Azmi Ahmed Hassali & Ali Qais Blebil. (2018) A cross-sectional survey to assess the knowledge, attitudes and common barriers to the reporting of adverse drug reactions by the general public in Malaysia. Journal of Pharmacy Practice and Research 48:4, pages 348-355.
Crossref
Crossref
Pacharaporn Phueanpinit, Juraporn Pongwecharak, Sermsak Sumanont, Janet Krska & Narumol Jarernsiripornkul. (2017) Physicians' communication of risks from non‐steroidal anti‐inflammatory drugs and attitude towards providing adverse drug reaction information to patients. Journal of Evaluation in Clinical Practice 23:6, pages 1387-1394.
Crossref
Crossref
Narumol Jarernsiripornkul, Arunrot Patsuree & Janet Krska. (2016) Public confidence in ADR identification and their views on ADRreporting: mixed methods study. European Journal of Clinical Pharmacology 73:2, pages 223-231.
Crossref
Crossref